Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010

Background: In Chile, gastric cancer (GC) is a major cause of cancer related deaths. The current screening strategy consists of an upper gastrointestinal endoscopy (UGE) for people aged 40 years or more with epigastric pain. Aim: To evaluate the diagnostic coverage of the use of UGE for early detect...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Latorre S,Gonzalo, Álvarez O,Jorge, Ivanovic-Zuvic S,Danisa, Valdivia C,Gonzalo, Margozzini M,Paula, Chianale B,José, Miquel P,Juan Francisco
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2015
Materias:	Health care surveys Mass screening Stomach neoplasms
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000900014
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872015000900014
record_format	dspace
spelling	oai:scielo:S0034-988720150009000142015-10-22Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010Latorre S,GonzaloÁlvarez O,JorgeIvanovic-Zuvic S,DanisaValdivia C,GonzaloMargozzini M,PaulaChianale B,JoséMiquel P,Juan Francisco Health care surveys Mass screening Stomach neoplasms Background: In Chile, gastric cancer (GC) is a major cause of cancer related deaths. The current screening strategy consists of an upper gastrointestinal endoscopy (UGE) for people aged 40 years or more with epigastric pain. Aim: To evaluate the diagnostic coverage of the use of UGE for early detection of GC in Chile. Material and Methods: As part of the digestive module of the 2009-10 National Health Survey, 5293 adults over 15 years were asked about the presence of epigastric pain, possible upper gastrointestinal bleeding (PUGB), use of proton pump inhibitors (PPIs) or histamine H2-receptor antagonists (H2RAs), family history of GC and having performed an UGE. Results: Persistent epigastric pain was observed in 3.4% of the population. PUGB signs were observed in 3.3% of the population. The prevalence of PPIs and H2RAs use was 4.3% and 2.2% respectively, reaching 21.6% in people aged 70 years and older. Life span prevalence of UGE was 18.3%, with differences by region, health insurance and educational level. UGE coverage in people aged 40 years or older with and without persistent epigastric pain was 14.4% and 3.2% respectively (Odds ratio 4.8, p < 0.01). The prevalence of UGE was similar among people with or without PUGB or family history of CG. Conclusions: The estimated coverage of the current GC prevention strategy in Chile is 14.4%, evaluated at a population level. Further studies are required to determine the impact of this strategy on early GC diagnosis and mortality.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.143 n.9 20152015-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000900014es10.4067/S0034-98872015000900014
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Health care surveys Mass screening Stomach neoplasms
spellingShingle	Health care surveys Mass screening Stomach neoplasms Latorre S,Gonzalo Álvarez O,Jorge Ivanovic-Zuvic S,Danisa Valdivia C,Gonzalo Margozzini M,Paula Chianale B,José Miquel P,Juan Francisco Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010
description	Background: In Chile, gastric cancer (GC) is a major cause of cancer related deaths. The current screening strategy consists of an upper gastrointestinal endoscopy (UGE) for people aged 40 years or more with epigastric pain. Aim: To evaluate the diagnostic coverage of the use of UGE for early detection of GC in Chile. Material and Methods: As part of the digestive module of the 2009-10 National Health Survey, 5293 adults over 15 years were asked about the presence of epigastric pain, possible upper gastrointestinal bleeding (PUGB), use of proton pump inhibitors (PPIs) or histamine H2-receptor antagonists (H2RAs), family history of GC and having performed an UGE. Results: Persistent epigastric pain was observed in 3.4% of the population. PUGB signs were observed in 3.3% of the population. The prevalence of PPIs and H2RAs use was 4.3% and 2.2% respectively, reaching 21.6% in people aged 70 years and older. Life span prevalence of UGE was 18.3%, with differences by region, health insurance and educational level. UGE coverage in people aged 40 years or older with and without persistent epigastric pain was 14.4% and 3.2% respectively (Odds ratio 4.8, p < 0.01). The prevalence of UGE was similar among people with or without PUGB or family history of CG. Conclusions: The estimated coverage of the current GC prevention strategy in Chile is 14.4%, evaluated at a population level. Further studies are required to determine the impact of this strategy on early GC diagnosis and mortality.
author	Latorre S,Gonzalo Álvarez O,Jorge Ivanovic-Zuvic S,Danisa Valdivia C,Gonzalo Margozzini M,Paula Chianale B,José Miquel P,Juan Francisco
author_facet	Latorre S,Gonzalo Álvarez O,Jorge Ivanovic-Zuvic S,Danisa Valdivia C,Gonzalo Margozzini M,Paula Chianale B,José Miquel P,Juan Francisco
author_sort	Latorre S,Gonzalo
title	Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010
title_short	Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010
title_full	Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010
title_fullStr	Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010
title_full_unstemmed	Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010
title_sort	cobertura de la estrategia preventiva de cáncer gástrico en chile: resultados de la encuesta nacional de salud 2009-2010
publisher	Sociedad Médica de Santiago
publishDate	2015
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000900014
work_keys_str_mv	AT latorresgonzalo coberturadelaestrategiapreventivadecancergastricoenchileresultadosdelaencuestanacionaldesalud20092010 AT alvarezojorge coberturadelaestrategiapreventivadecancergastricoenchileresultadosdelaencuestanacionaldesalud20092010 AT ivanoviczuvicsdanisa coberturadelaestrategiapreventivadecancergastricoenchileresultadosdelaencuestanacionaldesalud20092010 AT valdiviacgonzalo coberturadelaestrategiapreventivadecancergastricoenchileresultadosdelaencuestanacionaldesalud20092010 AT margozzinimpaula coberturadelaestrategiapreventivadecancergastricoenchileresultadosdelaencuestanacionaldesalud20092010 AT chianalebjose coberturadelaestrategiapreventivadecancergastricoenchileresultadosdelaencuestanacionaldesalud20092010 AT miquelpjuanfrancisco coberturadelaestrategiapreventivadecancergastricoenchileresultadosdelaencuestanacionaldesalud20092010
_version_	1718436843241865216

Cobertura de la estrategia preventiva de cáncer gástrico en Chile: resultados de la Encuesta Nacional de Salud 2009-2010

Ejemplares similares